Status:
COMPLETED
Study of the Complications Associated With Certain Stem Cell Transplants
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Post-Transplant Infections
Post-Transplant Renal Insufficiency
Eligibility:
All Genders
2+ years
Brief Summary
Background: \- The National Institutes of Health (NIH) performs up to 100 allogenic stem cell transplants (allo-HSCT) each year. Many studies already look at different problems that can follow a tran...
Detailed Description
Between 80 and 100 allogeneic stem cell transplants (allo-HSCT) are performed every year at the NIH to treat a variety of malignant and nonmalignant conditions. The current transplant protocols at the...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Subjects over the age of 2 that are actively enrolled in an allo-HSCT protocol at any NIH institute will be eligible to participate in this study regardless of gender or medical condition. Patients may be consented prior to and up to a week after receiving the stem cells (Day 0 of transplant).
- EXCLUSION CRITERIA:
- Subjects with any condition that, in the opinion of the investigator, contraindicates participation in the study will be excluded.
Exclusion
Key Trial Info
Start Date :
July 31 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 24 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01919099
Start Date
July 31 2013
End Date
August 24 2017
Last Update
March 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892